Dreyer Scott, EVP and Chief Commercial Officer at Collegium Pharmaceutical ($COLL), sold about $4.4 million in company shares across nine open market transactions over the past year. His most recent sale occurred on March 3, 2026. These sales rank him 2,126th among 11,678 insiders in our database by total value sold, below the average of $8.6 million per insider and 6.4 transactions. Dreyer Scott made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 3, 2026 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 3559 | $40.99 | 71,770.0000 | 40,076,457 | 4.72% | 0.01% |
| March 3, 2026 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 46417 | $40.36 | 75,329.0000 | 40,076,457 | 38.13% | 0.12% |
| Feb. 10, 2026 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 19023 | $0.00 | 122,636.0000 | 40,076,457 | 18.36% | 0.05% |
| Feb. 10, 2026 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 30702 | $0.00 | 153,338.0000 | 40,076,457 | 25.04% | 0.08% |
| Feb. 10, 2026 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 9977 | $46.75 | 143,361.0000 | 40,076,457 | 6.51% | 0.02% |
| Feb. 10, 2026 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 21615 | $46.75 | 121,746.0000 | 40,076,457 | 15.08% | 0.05% |
| Dec. 8, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 11125 | $47.89 | 110,088.0000 | 39,439,890 | 9.18% | 0.03% |
| Dec. 8, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | M | Stock Option (Right to Purchase) | 17600 | $0.00 | 0.0000 | 39,439,890 | 100.00% | 0.04% |
| Dec. 8, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 6475 | $48.66 | 103,613.0000 | 39,439,890 | 5.88% | 0.02% |
| Dec. 8, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | M | Common Stock | 17600 | $15.90 | 121,213.0000 | 39,439,890 | 16.99% | 0.04% |
| Aug. 18, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 16389 | $38.21 | 103,613.0000 | 39,075,703 | 13.66% | 0.04% |
| Aug. 18, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | M | Stock Option (Right to Purchase) | 16389 | $0.00 | 0.0000 | 39,075,703 | 100.00% | 0.04% |
| Aug. 18, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | M | Common Stock | 16389 | $21.34 | 120,002.0000 | 39,075,703 | 15.82% | 0.04% |
| Aug. 13, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | M | Stock Option (Right to Purchase) | 4861 | $0.00 | 16,389.0000 | 39,075,703 | 22.88% | 0.01% |
| Aug. 13, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 4861 | $38.03 | 103,613.0000 | 39,075,703 | 4.48% | 0.01% |
| Aug. 13, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | M | Common Stock | 4861 | $21.34 | 108,474.0000 | 39,075,703 | 4.69% | 0.01% |
| March 20, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 1927 | $30.00 | 122,494.0000 | 40,109,649 | 1.55% | 0.00% |
| March 21, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 18881 | $30.03 | 103,613.0000 | 40,109,649 | 15.41% | 0.05% |
| March 14, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 2255 | $30.00 | 124,421.0000 | 40,109,649 | 1.78% | 0.01% |
| March 11, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 15387 | $30.00 | 126,676.0000 | 40,109,649 | 10.83% | 0.04% |
| March 6, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 15387 | $30.00 | 126,676.0000 | 40,109,649 | 10.83% | 0.04% |
| March 6, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 3295 | $30.00 | 144,411.0000 | 40,109,649 | 2.23% | 0.01% |
| March 7, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 2348 | $30.00 | 142,063.0000 | 40,109,649 | 1.63% | 0.01% |
| Feb. 10, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 21670 | $30.52 | 147,706.0000 | 40,109,649 | 12.79% | 0.05% |
| Feb. 10, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 45016 | $0.00 | 150,918.0000 | 40,109,649 | 42.51% | 0.11% |
| Feb. 10, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 26411 | $0.00 | 177,329.0000 | 40,109,649 | 17.50% | 0.07% |
| Feb. 10, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 7953 | $30.52 | 169,376.0000 | 40,109,649 | 4.48% | 0.02% |
| May 24, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | M | Stock Option (Right to Purchase) | 23791 | $0.00 | 0.0000 | 41,438,466 | 100.00% | 0.06% |
| May 23, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | M | Stock Option (Right to Purchase) | 51209 | $0.00 | 23,791.0000 | 41,438,466 | 68.28% | 0.12% |
| May 24, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 56807 | $33.98 | 105,902.0000 | 41,438,466 | 34.91% | 0.14% |
| May 24, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | M | Common Stock | 23791 | $24.03 | 162,709.0000 | 41,438,466 | 17.13% | 0.06% |
| May 23, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 51209 | $33.82 | 138,918.0000 | 41,438,466 | 26.93% | 0.12% |
| May 23, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | M | Common Stock | 51209 | $24.03 | 190,127.0000 | 41,438,466 | 36.86% | 0.12% |
| Feb. 26, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 9336 | $36.38 | 139,582.0000 | 41,279,981 | 6.27% | 0.02% |
| Feb. 26, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 664 | $37.15 | 138,918.0000 | 41,279,981 | 0.48% | 0.00% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 10145 | $33.70 | 148,918.0000 | 41,279,981 | 6.38% | 0.02% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 19545 | $33.70 | 159,063.0000 | 41,279,981 | 10.94% | 0.05% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 32286 | $0.00 | 178,608.0000 | 41,279,981 | 22.07% | 0.08% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 35000 | $0.00 | 146,322.0000 | 41,279,981 | 31.44% | 0.08% |
| Jan. 16, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 23560 | $32.28 | 111,322.0000 | 41,279,981 | 17.47% | 0.06% |
| March 1, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 13324 | $26.70 | 134,882.0000 | 33,582,202 | 8.99% | 0.04% |
| Feb. 10, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 14529 | $26.75 | 155,003.0000 | 33,582,202 | 8.57% | 0.04% |
| Feb. 10, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 44275 | $0.00 | 147,073.0000 | 33,582,202 | 43.07% | 0.13% |
| Feb. 10, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | A | Common Stock | 22459 | $0.00 | 169,532.0000 | 33,582,202 | 15.27% | 0.07% |
| Feb. 10, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | F | Common Stock | 6797 | $26.75 | 148,206.0000 | 33,582,202 | 4.39% | 0.02% |
| Jan. 9, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 69 | $28.58 | 102,798.0000 | 33,582,202 | 0.07% | 0.00% |
| Jan. 9, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 7341 | $27.83 | 102,867.0000 | 33,582,202 | 6.66% | 0.02% |
| Jan. 9, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Dreyer Scott | EVP & Chief Commercial Officer | S | Common Stock | 10424 | $27.08 | 110,208.0000 | 33,582,202 | 8.64% | 0.03% |